Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open‐label, single‐arm, phase 2 study (ISRCTN34303497)

Saved in:
Bibliographic Details
Published in:British journal of haematology 2014-03, Vol.164 (6), p.888-890
Main Authors: Molyneux, Elizabeth, Merrick, Blair, Khanim, Farhat L., Banda, Kondwani, Dunn, Janet A., Iqbal, Gulnaz, Bunce, Christopher M., Drayson, Mark T.
Format: Article
Language:English
Subjects:
Adolescent
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
bezafibrate
Bezafibrate - administration & dosage
Biological and medical sciences
Burkitt lymphoma
Burkitt Lymphoma - drug therapy
Burkitt Lymphoma - epidemiology
Burkitt Lymphoma - pathology
Child
Child, Preschool
Drug Resistance, Neoplasm
efficacy
Endemic Diseases
Female
Hematologic and hematopoietic diseases
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Malawi - epidemiology
Male
Medical sciences
medroxyprogesterone
Medroxyprogesterone Acetate - administration & dosage
Recurrence
toxicity
Tumors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.12681